Treatment of acute Chlamydia pneumoniae infection with telithromycin in C57BL/6J mice

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 6, 2004, Pages 1101-1104

  Törmäkangas, Liisa ^a   Saario, E ^a   David, D Bem ^b   Bryskier, A ^b   Leinonen, M ^a   Saikku, P ^c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b SANOFI   (France)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Eradication; Ketolides; Lung infections

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BACTERIAL DNA; DOXYCYCLINE; ERYTHROMYCIN; KETOLIDE; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TELITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIUM CULTURE; BLOOD SAMPLING; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; HISTOPATHOLOGY; INFLAMMATION; INOCULATION; MOUSE; MOUSE STRAIN; NONHUMAN; POLYMERASE CHAIN REACTION; TISSUE CULTURE;

ACUTE DISEASE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DNA, BACTERIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOGLOBULIN G; INFLAMMATION; KETOLIDES; LUNG; MACROLIDES; MICE; MICE, INBRED C57BL; PNEUMONIA, BACTERIAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 3042554709     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh213     Document Type: Article

References (10)

1. Hahn, D. L., Azenabor, A. A., Beatty, W. L. et al. (2002). Chlamydia pneumoniae as a respiratory pathogen. Frontiers in Bioscience 7, e66-76.
2. Hahn, D. L., Dodge, R. W. & Golubjatnikov, R. (1991). Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. Journal of the American Medical Association 266, 225-30.
3. Danesh, J., Collins, R. & Peto, R. (1997). Chronic infections and coronary heart disease: is there a link? Lancet 350, 430-6.
4. Malinverni, R., Kuo, C. C., Campbell, L. A. et al. (1995). Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis. Antimicrobial Agents and Chemotherapy 39, 45-9.
5. Masson, N. D., Toseland, C. D. & Beale, A. S. (1995). Relevance of Chlamydia pneumoniae murine pneumonitis model to evaluation of antimicrobial agents. Antimicrobial Agents and Chemotherapy 39, 1959-64.
6. Bin, X. X., Wolf, K., Schaffner, T. et al. (2000). Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice. Antimicrobial Agents and Chemotherapy 44, 1761-4.
7. Malinverni, R., Kuo, C. C., Campbell, L. A. et al. (1995). Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. Journal of Infectious Diseases 172, 593-4.
8. Bryskier, A. (2000). Ketolides-telithromycin, an example of a new class of antibacterial agents. Clinical Microbiology and Infection 6, 661-9.
9. Roblin, P. M. & Hammerschlag, M. R. (1998). In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. Antimicrobial Agents and Chemotherapy 42, 1515-6.
10. Erkkila, L., Laitinen, K., Laurila, A. et al. (2002). Experimental Chlamydia pneumoniae infection in NIH/S mice: effect of reinoculation with chlamydial or cell preparation on culture, PCR and histological findings of lung tissue. Vaccine 20, 2318-24.